Everads Therapy

Developer of retinal treatment therapy and technology designed to overcome significant technical challenges in effective suprachoroidal injection.

Health Tech & Life Sciences
Active
Seed Tel Aviv-Yafo, Israel Founded 2017
Last updated 2026-07-26
Total raised
$1.0M
Last: Undisclosed Round 2017-01
Stage
Seed
Founded
2017
Headcount
9
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences

About

Everads Therapy is a clinical-stage biotechnology company advancing the treatment of retinal diseases through its proprietary suprachoroidal delivery platform. The company's technology is designed for rapid, broad, and safe drug distribution in the suprachoroidal space via a non-surgical, office-based injection. Everads is also developing this platform for in-office suprachoroidal buckling to treat select retinal detachments. The company collaborates with partners across gene therapy, cell therapy, small molecule formulations, and other modalities. Everads was founded as a spin-out from DALI Medical Devices and established within RAD Biomed, a biotech accelerator, with core technologies licensed from the laboratory of Prof. Y Rotenstreich at the Sheba Tel Hashomer Medical Center / Sheba Impact.

Funding history · 1 round · $1.0M total

2016-12
Seed $1.0M
★ RAD BioMed★ EU Horizon 2020

Headcount over time

From 1 (2019-05) to 10 (2025-10) · +9 (+900%) · 20 points · source: Finder history + radar grounding
120 2019-05 2025-10

Q&A

What is Everads Therapy's primary focus?
Everads Therapy is an early-stage life sciences company developing retinal treatment delivery technologies, aiming to improve the efficacy and safety of injectable therapies into the eye.
When was Everads Therapy founded?
Everads Therapy was founded in January 2017.
Where is Everads Therapy headquartered?
Everads Therapy is headquartered in Tel Aviv-Yafo, Israel.
How much funding has Everads Therapy raised to date?
Everads Therapy has raised a total of $1,000,000.
Which investors participated in Everads Therapy's funding round?
In January 2017, Everads Therapy received funding from EU Horizon 2020 and RAD BioMed.
What is the current employee count for Everads Therapy?
Everads Therapy has 1-10 employees.
Who are the co-founders of Everads Therapy?
The co-founders of Everads Therapy are Dr. Ifat Sher (CSO), Dr. Ygal Rotenstreich (Medical Director), and David Daily (R&D Director).
What is Everads Therapy's current product stage?
Everads Therapy's product is currently in the R&D stage.

Team · 4

Ygal Rotenstreich
Founder · Co-Founder
Ifat Sher
Founder · Co-Founder
Lior Raday
Founder · Co-Founder
David Daily
Founder · Co-Founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsPharma & Medical BiotechnologyDrug Delivery
Target customers
Healthcare & Life SciencesHealthcareProvidersLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 PatentsVerified

Tags

cell-therapyophthalmologymedical-devicesclinicshospitalsbiotechnologydoctorsdrug-deliverymedical-technologieseye-diseasesminimally-invasivenanotechnology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteeverads-therapy.com/
LinkedInlinkedin.com/company/17988603

Identifiers & details

Legal nameEverads Therapy Ltd.
Founded2017
Employees (exact)9

Radar intelligence

Patents

EPO6

Web history (Wayback)

Domaineverads-therapy.com

Certificate / subdomain footprint

Subdomains1

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)515541324
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2016-11-02
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2026
Active charges / liens0
Registry events2 — annual_report (1), shares_capital (1)
Registered addressהברזל 31 תל אביב - יפו

Recent registry events

DateEvent
2026-06-15דו~ח שנתי
2026-05-06הקצאת מניות